Litcius/Paper detail

Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells

Niloufar Rezaei, Mandana Kazem Arki, Zohreh Miri-Lavasani, Roya Solhi, Mahsa Khoramipour, Hamid Rashedi, Hamid Asadzadeh Aghdaei, Nikoo Hossein‐Khannazer, Ebrahim Mostafavi, Massoud Vosough

2023European Journal of Pharmaceutics and Biopharmaceutics22 citationsDOI

Topics & Concepts

NiosomePaclitaxelApoptosisNanocarriersPharmacologyDoxorubicinCancerCancer cellChemistryDrug deliveryMTT assayIC50Cancer researchDrugMedicineIn vitroChemotherapyVesicleBiochemistryInternal medicineMembraneOrganic chemistryNanoparticle-Based Drug DeliveryCancer Cells and MetastasisCaveolin-1 and cellular processes
Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells | Litcius